Mechanisms of long-term taste loss in post-acute sequelae of COVID-19
Mechanisms of long-term taste loss in post-acute sequelae of COVID-19
批准号:
10554842
负责人:
Hong Wang
金额:
$42.33万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2026-03-31
关键词:
2019-nCoVACE2AcuteAdministrative SupplementAffectAgeusiaAmericanAnimal ModelAnxietyAwardBody Weight decreasedCOVID-19COVID-19 patientCOVID-19 severityCell DeathCell Differentiation processCellsColoradoDefectDiseaseEnvironmental Risk FactorExhibitsFailureFunctional disorderFutureGenesGeneticGoalsGrantHealthHigh PrevalenceHumanIFNAR1 geneIL8 geneIRF3 geneImmune responseImmunologyIn VitroInfectionInflammationInflammatoryInjuryInterferon Type IInterferonsInterleukin-18Interleukin-6Knock-inKnock-outKnockout MiceLeadLongevityMalnutritionMediatingMental DepressionMolecularMucous MembraneMusMutationNatural regenerationNewborn InfantOrganoidsPaperPathologicPathway interactionsPatientsPersonal SatisfactionPersonsPlayPositioning AttributePost-Acute Sequelae of SARS-CoV-2 InfectionProcessProliferatingPublishingQuality of lifeRecoveryReportingResearchResearch PersonnelRoleSARS-CoV-2 infectionSalivaSeveritiesSignaling ProteinStructure of parenchyma of lungSymptomsTLR3 geneTNF geneTaste Bud CellTaste BudsTaste DisordersTaste PerceptionTestingTherapeutic InterventionTissuesToll-like receptorsUniversitiesViralVirus Diseasesbody systemcell regenerationcytokineeffective therapyin vivo evaluationinsightlung injurymouse modelnerve supplypathogenic viruspost-COVID-19progenitorpublic health relevancereceptorregeneration modelsevere COVID-19stem cellstherapy developmenttreatment strategytype I interferon receptor
中文摘要
项目摘要
SARS-CoV-2已感染全球超过3.4亿人,其中包括超过7000万美国人。大约40-45%
这些患者报告了味觉异常。虽然许多患者的味觉功能很快恢复,
最近的研究表明,大约10-20%的患者患有持续的味觉丧失,持续时间超过6
个月长期味觉丧失会显著影响健康-降低生活质量,
营养不良焦虑和抑郁目前,长期味觉丧失的机制与
人们对COVID-19感染知之甚少,也没有有效的治疗方法。为了开发
治疗策略,有必要确定哪些因素导致长期味觉丧失。多
抗病毒机制已经发展到保护我们免受大量病毒病原体的侵害。但这些
遗传或环境因素会削弱这些机制。最近的研究表明,
一些抗病毒基因的错误会导致COVID-19的严重性,但这些遗传错误是否也
导致严重的,长期的味觉丧失是未知的。在本研究中,我们将使用动物模型来模拟
在抗病毒途径中存在先天性遗传错误的患者,以专门研究这些基因是否以及如何在
遗传缺陷导致急性COVID-19后长期味觉丧失。我们将进一步确定是否和
宿主免疫反应中的哪些炎症因子抑制味蕾再生,从而有助于
持续的味觉丧失这项研究中确定的机制也可能适用于其他慢性疾病的长期症状。
器官系统,并帮助开发长期化学感觉丧失的治疗方法。
英文摘要
PROJECT SUMMARY
SARS-CoV-2 has infected >340 million people worldwide, including >70 million Americans. Roughly 40-45% of
these patients have reported taste abnormalities. While taste function is restored quickly in many patients,
recent studies show that about 10-20% of patients suffer from sustained taste loss that lasts longer than 6
months. Long-term taste loss significantly impacts health – decreasing quality of life and contributing to
malnutrition, anxiety, and depression. Currently, the mechanism of long-term taste loss associated with
COVID-19 infection is poorly understood, and there is no effective treatment for it. In order to develop
treatment strategies, it is necessary to determine what factors contribute to long-term taste loss. Multiple
antiviral mechanisms have evolved to protect us from the vast number of viral pathogens. However, these
mechanisms can be weakened by genetic or environmental factors. Recent studies show that inborn genetic
errors in some antiviral genes contribute to the severity of COVID-19, but whether these genetic errors also
contribute to severe, long-term taste loss is unknown. In this study, we will use animal models to simulate
patients with inborn genetic errors in antiviral pathways to specifically investigate whether and how these
genetic defects contribute to long-term taste loss after acute COVID-19. We will further determine whether and
which inflammatory factors in host immune responses inhibit taste bud regeneration and thus contribute to
sustained taste loss. Mechanisms identified in this study may also apply to long-lasting symptoms in other
organ systems and help to develop treatments for long-term chemosensory loss.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of inflammation-triggered taste loss and its recovery
-
批准号:10359837
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2021
-
负责人:Hong Wang
-
依托单位:
Core 2: Biostatistics and Bioinformatics Core
-
批准号:10469634
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2021
-
负责人:Hong Wang
-
依托单位:
Mechanisms of inflammation-triggered taste loss and its recovery
-
批准号:10211925
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2021
-
负责人:Hong Wang
-
依托单位:
Core 2: Biostatistics and Bioinformatics Core
-
批准号:10683755
-
项目类别:
-
资助金额:$26.2万
-
财政年份:2021
-
负责人:Hong Wang
-
依托单位:
Mechanisms of inflammation-triggered taste loss and its recovery
-
批准号:10599864
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2021
-
负责人:Hong Wang
-
依托单位:
Sequence and Structure Specific DNA Binding by Cohesin and Genome Stability
-
批准号:10175465
-
项目类别:
-
资助金额:$11.4万
-
财政年份:2018
-
负责人:Hong Wang
-
依托单位:
CD40 monocyte in chronic kidney disease
-
批准号:9331901
-
项目类别:
-
资助金额:$63.48万
-
财政年份:2017
-
负责人:Hong Wang
-
依托单位:
Mechanisms of inflammation-triggered taste loss and its recovery
-
批准号:9527911
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2017
-
负责人:Hong Wang
-
依托单位:
CD40 monocyte in chronic kidney disease
-
批准号:9897533
-
项目类别:
-
资助金额:$71.4万
-
财政年份:2017
-
负责人:Hong Wang
-
依托单位:
HHcy-induced Inflammatory Monocyte and Macrophage Differentiation in Diabetes
-
批准号:8969420
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2015
-
负责人:Hong Wang
-
依托单位:
Hyperhomocysteinemia and HDL Metabolism
-
批准号:8792030
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2013
-
负责人:Hong Wang
-
依托单位:
Hyperhomocysteinemia and HDL Metabolism
-
批准号:8605915
-
项目类别:
-
资助金额:$52.27万
-
财政年份:2013
-
负责人:Hong Wang
-
依托单位:
Hyperhomocysteinemia and HDL Metabolism
-
批准号:8984907
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2013
-
负责人:Hong Wang
-
依托单位:
Hyperhomocysteinemia and HDL Metabolism
-
批准号:8463683
-
项目类别:
-
资助金额:$54.67万
-
财政年份:2013
-
负责人:Hong Wang
-
依托单位:
DNA damage induced structural and dynamic changes at telomeres
-
批准号:8664385
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2012
-
负责人:Hong Wang
-
依托单位:
DNA damage induced structural and dynamic changes at telomeres
-
批准号:8335507
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Hong Wang
-
依托单位:
DNA damage induced structural and dynamic changes at telomeres
-
批准号:8468177
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2012
-
负责人:Hong Wang
-
依托单位:
NADHP Oxidase-mediated MC differentiation & Endothelial Dysfunction in HHcy
-
批准号:8321485
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2011
-
负责人:Hong Wang
-
依托单位:
NADHP Oxidase-mediated MC differentiation & Endothelial Dysfunction in HHcy
-
批准号:8476266
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2011
-
负责人:Hong Wang
-
依托单位:
NADHP Oxidase-mediated MC differentiation & Endothelial Dysfunction in HHcy
-
批准号:8206237
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2011
-
负责人:Hong Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: